Laboratory Of America Holdings Shares Outstanding 2006-2018 | LH

Laboratory Of America Holdings shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Laboratory Of America Holdings shares outstanding for the quarter ending September 30, 2018 were 0.103B, a 0.96% decline year-over-year.
  • Laboratory Of America Holdings 2017 shares outstanding were 0.104B, a 0.38% decline from 2016.
  • Laboratory Of America Holdings 2016 shares outstanding were 0.104B, a 3.68% increase from 2015.
  • Laboratory Of America Holdings 2015 shares outstanding were 0.101B, a 16.44% increase from 2014.
Laboratory Of America Holdings Annual Shares Outstanding
(Millions of Shares)
2017 104
2016 104
2015 101
2014 86
2013 92
2012 97
2011 102
2010 105
2009 109
2008 112
2007 121
2006 135
2005 145
Laboratory Of America Holdings Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 103
Q2 2018 103
Q1 2018 103
Q4 2017 104
Q3 2017 104
Q2 2017 104
Q1 2017 104
Q4 2016 104
Q3 2016 105
Q2 2016 104
Q1 2016 104
Q4 2015 101
Q3 2015 103
Q2 2015 103
Q1 2015 94
Q4 2014 86
Q3 2014 87
Q2 2014 86
Q1 2014 87
Q4 2013 92
Q3 2013 91
Q2 2013 94
Q1 2013 95
Q4 2012 97
Q3 2012 97
Q2 2012 98
Q1 2012 99
Q4 2011 102
Q3 2011 102
Q2 2011 103
Q1 2011 103
Q4 2010 105
Q3 2010 104
Q2 2010 105
Q1 2010 107
Q4 2009 109
Q3 2009 109
Q2 2009 110
Q1 2009 109
Q4 2008 112
Q3 2008 112
Q2 2008 114
Q1 2008 114
Q4 2007 121
Q3 2007 121
Q2 2007 122
Q1 2007 123
Q4 2006 135
Q3 2006 137
Q2 2006 136
Q1 2006 137
Q4 2005 145
Q3 2005 146
Q2 2005 146
Q1 2005 146
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.168B $10.441B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.088B 22.17
McKesson (MCK) United States $25.557B 9.76
AmerisourceBergen (ABC) United States $19.225B 13.71
Align Technology (ALGN) United States $18.873B 48.15
Cardinal Health (CAH) United States $16.479B 11.06
Cooper (COO) United States $13.160B 23.70
Henry Schein (HSIC) United States $13.023B 21.41
West Pharmaceutical Services (WST) United States $8.221B 40.80
DENTSPLY SIRONA (XRAY) United States $8.025B 16.03
Merit Medical Systems (MMSI) United States $3.238B 38.42
Patterson (PDCO) United States $2.259B 15.88
STAAR Surgical (STAA) United States $2.074B 213.64
CONMED (CNMD) United States $1.944B 32.29
Atrion (ATRI) United States $1.321B 37.76
Antares Pharma (ATRS) United States $0.573B 0.00
Invacare (IVC) United States $0.230B 0.00
Lifevantage (LFVN) United States $0.167B 23.70
Endologix (ELGX) United States $0.115B 0.00
Aceto (ACET) United States $0.055B 0.00
Pro-Dex (PDEX) United States $0.051B 32.63
Biolase (BIOL) United States $0.030B 0.00